Fundraise for Fred Hutch

Find a Fundraiser or Team

Create a Fundraiser

My Dashboard

Team Fundraiser

 Fundraise for Fred Hutch

get creative

Target Pediatric AML

Team Captain:

Co-Captain:

Donate To Our Team Join Our Team

TEAM PROGRESS

$28,132.50

RAISED

of our

$250,000.00

GOAL

OUR DONORS

Share our page

Thanks for your patience as we load our team roster.

Loading

Update your profile picture

Please note: Your photo must be a JPG or PNG less than 4 megabytes and 6 million pixels.
For best results, your photo should be sized at 500 x 500 pixels.
Other sizes in a 1:1 aspect ratio will work (e.g. 800 x 800 pixels).

Get Creative

Support Target Pediatric AML!
Team Progress
Goal:
$250,000.00
Achieved:
$28,132.50
Make a gift!
11 percent of goal achieved.
Team Honor Roll
Top Donors

Southwest San Diego Lions Club

Benjamin's Hope for the Future Foundation

Friends of Mary Witherspoon

Miranda Dawdy

Randall and Mickey Bourne

Full Donor List Full Donor List


AML is the deadliest leukemia across all ages. Therapies for AML have not changed significantly in decades, so it remains one of the poorest prognosis, most harrowing, and costly pediatric cancers. But, hope is on the horizon. Targeted agents, like T-cell therapies and small molecule inhibitor drugs, offer the possibility of near-term breakthroughs. However, the effectiveness of these cutting-edge, precision treatments depends largely on one critical element – identification of GOOD TARGETS. The issue of effective targeting remains a barrier to progress in AML. With your help, in collaboration with others across the country, we can change this.

Target Pediatric AML (tpAML) seeks to speed access to promising targeted therapies and begin the shift from the virtual “one-size-fits-all” protocols of today to more personalized, precision treatment regimens tailored to a young AML patient’s specific cancer profile (genetics). This should not only improve outcomes, but reduce both short and long-term treatment-related toxicities. This effort is led by Dr. Soheil Meshinchi, a renowned pediatric AML researcher and Fred Hutch faculty member. He is also the Children’s Oncology Group’s AML biology chair and oversees the world’s largest pediatric AML tissue repository, which resides on the Fred Hutch campus in Seattle.
TpAML is a multi-year, $10 million effort that seeks to jumpstart access to more personalized, precision treatment regimens for pediatric AML patients. TpAML is not a foundation – it is a nationwide, volunteer-led, fundraising and “funds-pooling” initiative to accelerate the highest priority Children's Oncology Group AML research project.

Watch our video to learn more: https://www.youtube.com/watch?v=44dsu9FETUY.

Contact Nicole Pratapas in the Fred Hutch Development Office at 206-667-5190 or email npratapa@fredhutch.org if you wish to learn more.

Please join our team to help us accelerate promising new therapies for pediatric AML families today and in the future!

Target Pediatric AML - Join Team Raised
Target Pediatric AML $27,882.50
Team Gifts $250.00
Denotes a Team Captain

  • A Comprehensive Cancer Center Designated by the National Cancer Institute
  • National Comprehensive Cancer Network

  • AAHRPP logo
  • Forbes 2018 - America's Best Mid-Size Employers
  • Candid Gold logo

Fred Hutch is proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. 
Read the Know your Rights: Workplace Discrimination is Illegal Poster.